Influence of ovariectomy and flutamide treatment on vaginal tissue and body weight

Saudi Medical Journal

Volumn 26, Issue 12, 2005, Pages 1897-1903

  Saruhan, Berna G ^a   Ozbag, Davut ^b   Gumusalan, Yakup ^b   Ozdemir, Nurullah ^a  

^a DICLE UNIVERSITY   (Turkey)

^b KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; FLUTAMIDE;

ANATOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT DISORDER; CONTROLLED STUDY; DRUG MECHANISM; ESTROGEN ACTIVITY; FEMALE; FEMALE GENITAL SYSTEM FUNCTION; HISTOLOGY; KERATINIZATION; MEDICAL RESEARCH; NONHUMAN; OVARIECTOMY; RAT; RAT STRAIN; REGULATORY MECHANISM; SEXUAL MATURATION; STROMA CELL; THICKNESS; VAGINA EPITHELIUM;

ANDROGEN ANTAGONISTS; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; FEMALE; FLUTAMIDE; IMMUNOHISTOCHEMISTRY; OVARIECTOMY; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; VAGINA;

EID: 31844442903     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Balk P. Androgen receptor as a target in androgen-independent prostate cancer. Urology 2002; 60: 132-138.
2. Clemens LG, Gladue BA, Coniglo LP. Prenatal endogenous androgenic influences on masculine sexual behaviour and genital morphology in male and female rats. Horm Behav 1978; 10: 40-53.
3. Brand T, Slob AK. Perinatal flutamide and mounting and lordosis behaviour in adult female Wistar and Spraque-Dawley rats. Behav Brain Res 1991; 44: 43-51.
4. Zimmerberg B, Farley MJ. Sex differences in anxiety behaviour in rats: Role of gonadal hormones. Physiol Behav 1993; 54: 1119-1124.
5. Lund TD, Salyer DL, Fleming DE, Lephart ED. Pre-and postnatal testosterone and flutamide effects on sexually dimorphic nuclei of the rat hypothalamus. Brain Res Dev Brain Res 2000; 120: 261-266.
6. Gladue BA, Clemens LG. Androgenic influences on feminine sexual behaviour in male and female rats: Defeminization blocked by prenatal androgen treatment. Endocrinology 1978; 103: 1702-1709.
7. Matusczyk JV, Larsson K. Sexual preference and feminine and masculine sexual behaviour of male rats parentally exposed to antiandrogen or antiestrogen. Horm Behav 1995; 29: 191-206.
8. Miyata K, Yabushita S, Sukata T, Sano M, Yoshino H, Nakanishi T, Okuda Y, Matsuo M. Effects of perinatal exposure to flutamide on hormones and androgen dependent organs in F1 male rats. J Toxicol Sci 2002; 27: 19-33.
9. Wu FC. Testicular steroidogenesis and androgen use and abuse. Baillieres Clin Endocrinol Metab 1992; 6: 373-403.
10. Bagatell CJ, Bremner WJ. Androgens in men-uses and abuses. N Engl J Med 1996; 334: 707-714.
11. Neumann F. Pharmacology and clinical use of antiandrogens: a short review. Ir J Med Sci 1982; 151: 61-70.
12. McLeod DG. Antiandrogenic drugs. Cancer 1993; 71: 1046-1049.
13. Neri R, Peets E, Watnick A. Anti-androgenicity of flutamide and its metabolite Sch 16423. Biochem Soc Trans 1979; 7: 565-569.
14. Cockshott ID, Copper KJ, Sweetmore DS, Blacklock NJ, Dennis L. The pharmacokinetics of casodex in prostate cancer patients after single and during multiple dosing. Eur Urol 1990; 18: 10-17.
15. Teutsch G, Goubet F, Battmann T, Bonfils A, Bouchoux F, Cerede E, et al. Nonsteroidal antiandrogens: synthesis and biological profile of high- affinity ligands for the androgen receptor. J Steroid Biochem Mol Biol 1994; 48: 111-119.
16. Hamann LG, Winn DT, Pooley CL, Tegley CM, West SJ, Farmer LJ, et al. Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro 2,2,4 trimethylquinolines. Bioorg Med Chem Lett 1998; 8: 2731-2736.
17. Mitlak BH, Cohen FJ. Selective estrogen receptor modulators: a look ahead. Drugs 1999; 57. 653-663.
18. Weryha G, Pascal-Vigneron V, Klein M, Leclere J. Selective estrogen receptor modulators. Curr Opin Rheumatol 1999; 11: 301-306.
19. Zhi L, Tegley CM, Kallel EA, Marschke KB, Mais DE, Gottardis MM, et al. 5 Aryl-1,2-dihydrochromenol (3,4) flquinolines: a novel class of nonsteroidal human progesterone receptor agonist. J Med Chem 1998; 41: 291-302.
20. Zhi L, Tegley CM, Pio B, West SJ, Marschke KB, Mais DE et al. Nonsteroidal progesterone receptor antagonists based on 6-thiophenehydroquinolines. Bioorg Med Chem Lett 2000; 10: 415-418.
21. Wilson JD. Androgen abuse by athletes. Endocrine Reviews 1988; 9: 181-199.
22. Bahrke MS, Yesalis CE, Brower KJ. Anabolic-androgenic steroid abuse and performance enhancing drugs among adolescents. Child Adolesc Psychiatr Clin N Am 1998; 7: 821-838.
23. Strauss RH, Liggett MT, Lanese RR. Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA 1985; 253: 2871-2873.
24. Strauss RH, Yesalis CE. Additional effects of anabolic steroids on women. In: Yesalis CE, editor. Anabolic Steroids in Sport and Exercise. Champaign IL: Human Kinetics Publishers; 1993. p. 151-160.
25. Yesalis CE, Barsukiewicz CK, Kopstein AN, Bahrke MS. Trends in anabolic- androgenic steroid use among adolescents. Arch Pediatr Adolesc Med 1997; 151: 1197-1206.
26. Copeland J, Peters R, Dillon P. A study of 100 anabolic-androgenic steroid users. Med J Aust 1998; 168: 311-312.
27. Ramirez VD, Sawyer CH. Advancement of puberty in the female rat by estrogen. Endocrinology 1965; 76: 1158-1189.
28. Ojeda SR, Urbanski HF. Puberty in the rat. In: Knobil E, Neil JD, editors. The Physiology of Reproduction, 2nd ed. New York: Raven Press; 1994. p. 363-409.
29. Knop RH. Risk factors for coronary artery disease in women. Am J Cardiol 2002; 89: 28-34.
30. Baum MJ, Sodersten P, Vreeburg JTM. Mounting and receptive behaviour in the ovariectomized female rats: Influence of estradiol, dihydrotestosterone, and genital anesthetization. Horm Behav 1974; 5: 175-190.
31. Dohanich GP, Clemens LG. Inhibition of estrogen activated sexual behaviour by androgens. Horm Behav 1983; 17: 366-373.
32. Blasberg ME, Clark AS. Anabolic androgenic steroid effects on sexual receptivity in ovariectomized rats. Horm Behav 1997; 32: 201-208.
33. Simard J, Luthy I, Guay J, Belanger A, Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol 1986; 44: 261-270.
34. Erskine MS, Marcus JI, Baum MJ. Effect of antiandrogen and 5α reductase inhibitor on hormone induced sexual behaviour during pregnancy in the rat. Biol Reprod 1980; 23: 767-775.
35. Erskine MS. Effect of 5α dihydrotestosterone and flutamide on the facilitation of lodosis by LHRH and naloxone in estrogen primed female rats. Physiol Behav 1989; 45: 753-759.
36. Lerner LJ, Hilf R. Effects of hormone antagonists on morphological and biochemical changes induced by hormonal steroids in the immature rat uterus. Recent Prog Horm Res 1964; 20: 721-726.
37. Donghua Y, Yali HE, Minoli A. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Mol Pharmacol 2003; 63: 211-223.
38. Karnam RP, Pao LW, Calogero D. Effects of surgical ovariectomy on rat salivary gland function. Arch Oral Biol 1993; 38: 779-784.
39. Furr BJA, Jordan VC. The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 1984; 25: 127-130.
40. Taguchi O, Cunha GR, Robboy SJ. Experimental study of the effect of diethylstilbestrol on the development of the human female reproductive tract. Biol Res Pregnancy Perinatol 1983; 4: 56-58.
41. Clark JH, McCormack SA, Kling R. Effect of clomiphene and other triphenylethylene derivatives on the reproductive tract in the rat and baboon. Hormones and Cancer. New York: Raven Press; 1980. p. 295.
42. Taguchi O, Nishizuka Y. Reproductive tract abnormalities in female mice treated neonatally with tamoxifen. Am J Obstet Gynecol 1985; 151: 675-677.
43. Simard J, Luthy I, Guay J. Characteristic of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol 1986; 44: 261-270.
44. Lerner LJ. Hormone antagonists, inhibitors of specific activities of estrogen and androgen. Recent Prog Horm Res 1964; 20: 435-490.
45. Lerner LJ, Hilf R. Effects of Hormone antagonists on morphological and biochemical changes induced by hormonal steroids in the immature rat uterus. Recent Prog Horm Res 1964; 20: 435-490.
46. Gonzalez M. Diddi B. Komisaruk CB. Differential effects of testosterone and dihydrotestosterone on the diverse uterine tissues of the ovariectomized rat. Endocrinology 1972; 20: 1129-1132.
47. Lyon MF, Glenister PH. Evidence from tfm/o that androgen is inessential for reproduction in female mice. Nature 1974; 247: 366-367.
48. Guerami A. Griffin JE. Kovacs WJ. Estrogen and androgen production rates in the two brothers with Reinfenstein syndrome. J Clin Endocrinol Metab 1990; 71: 247-251.
49. Beri R, Kumar N. Estrogenic and progestational activity of 7α-methyl-19 nortestosterone a synthetic androgen. J Steroid Biochem Mol Biol 1998; 67: 275-283.
50. Fekete G. Chemistry pharmacology and clinical pharmacology of oral contraceptives. Ther Hung 1968; 16: 1-8.
51. Saruhan BG, Nergiz Y. Histological Effect of Estrogens and Anti-estrogens on uterinal epithelium in estrogen deficiency induced rats. Journal of Dicle Medicine 2002; 29: 1-2.
52. Saruhan BG, Nergiz Y. Histological Effect of Estrogens and Anti-estrogens on vaginal epithelium in estrogen deficiency induced rats. The Chamber of Medicine of Istanbul, Journal of Clinical Development 2003; 16: 1-5.
53. Park SM, Park CH, Wha JD. A high carbohydrate diet induces insulin resistance through decreased glucose utilization in ovariectomized rats. Korean J Intern Med 2004; 19: 87-92.
54. Blaustein JD, Gentry RT, Roy EJ. Effects of ovariectomy and estradiol on body weight and food intake in gold thioglucose treated mice. Physiol Behav 1976; 17: 1027-1030.
55. Mei LL, Xia X, Wei QR. Influence of ovariectomy and 17-β estradiol treatment on insulin sensitivity, lipid metabolism and post ischemic cardiac function. Int J Cardiol 2004; 97: 485-493.
56. Saglam K, Polat Z, Yilmaz IM. Effects of postmenopausal hormone replacement therapy on insulin resistance. Endocrine 2002; 18: 211-214.